85390 Fibrinolysins or coagulopathy screen, interpretation and report

Name of the Procedure:

• Fibrinolysis or Coagulopathy Screen, Interpretation, and Report
• Commonly referred to as "Coagulation Screening" or "Fibrinolysis Testing."

Summary

A Fibrinolysis or Coagulopathy Screen is a series of blood tests designed to evaluate how well your blood clots and dissolves clots. These tests help diagnose conditions that affect blood clotting and bleeding.

Purpose

This procedure aims to identify potential clotting disorders such as hemophilia, von Willebrand disease, or disseminated intravascular coagulation (DIC). The goal is to diagnose bleeding disorders, monitor treatment effectiveness, and guide treatment decisions.

Indications

• Unusual or excessive bleeding or bruising
• History of blood clots or a family history of clotting disorders
• Pre-surgical screening for bleeding risk
• Unexplained prolonged bleeding
• Monitoring of anticoagulant therapy effectiveness

Preparation

• Patients may need to fast for a few hours before the test.
• Inform the healthcare provider of any medications being taken, as some may need to be adjusted or paused.
• No specific physical preparation is usually required.

Procedure Description

1. Blood Sample Collection: A healthcare professional will draw blood from a vein, usually in the arm, using a sterile needle and syringe.
2. Laboratory Analysis: The sample is sent to a laboratory where various tests are conducted to assess clotting factors, fibrinogen levels, platelet function, and other related parameters.
3. Interpretation: A hematologist or a specialized doctor reviews the test results to identify any abnormalities in the clotting process.
4. Reporting: The healthcare provider will compile a detailed report, which includes the test results and their interpretation.

Duration

• The blood sample collection takes approximately 5-10 minutes.
• Laboratory analysis and interpretation can take several hours to a few days, depending on the tests involved.

Setting

• This procedure is typically performed in a hospital, outpatient clinic, or specialized laboratory.

Personnel

• Phlebotomist or nurse for blood sample collection.
• Laboratory technicians for sample analysis.
• Hematologist or specialized doctor for interpretation and report preparation.

Risks and Complications

• Minor discomfort or pain at the needle insertion site.
• Rare complications include bleeding, bruising, or infection at the puncture site.
• Very rarely, fainting or dizziness may occur during or after blood draw.

Benefits

• Accurate diagnosis of bleeding and clotting disorders.
• Guidance for appropriate medical treatment and management.
• Monitoring of already diagnosed conditions to adjust therapy as needed.

Recovery

• No significant recovery time required.
• Patients might experience minor discomfort at the needle site, which typically resolves quickly.
• Follow-up appointments may be scheduled to discuss results and plan further treatment.

Alternatives

• Radiologic imaging or other types of blood tests to assess clotting issues.
• Genetic testing for hereditary clotting disorders.
• Each alternative has specific advantages and disadvantages, which should be discussed with the healthcare provider.

Patient Experience

• During the procedure: Patients might feel a brief sting or pinch when the needle is inserted.
• After the procedure: Some soreness or bruising might occur at the puncture site; this can be managed with over-the-counter pain relievers and warm compresses.
• Most patients can resume normal activities immediately after the blood draw.